Chen, H.; Yan, J.; Liu, Z.; Ge, X.; Sun, X.; Xia, X.
Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing Chemotherapy. Curr. Oncol. 2025, 32, 189.
https://doi.org/10.3390/curroncol32040189
AMA Style
Chen H, Yan J, Liu Z, Ge X, Sun X, Xia X.
Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing Chemotherapy. Current Oncology. 2025; 32(4):189.
https://doi.org/10.3390/curroncol32040189
Chicago/Turabian Style
Chen, Hui, Jingze Yan, Zeyuan Liu, Xiaolin Ge, Xinchen Sun, and Xiaojie Xia.
2025. "Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing Chemotherapy" Current Oncology 32, no. 4: 189.
https://doi.org/10.3390/curroncol32040189
APA Style
Chen, H., Yan, J., Liu, Z., Ge, X., Sun, X., & Xia, X.
(2025). Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing Chemotherapy. Current Oncology, 32(4), 189.
https://doi.org/10.3390/curroncol32040189